The revenue stands at ₹580.39 crore, reflecting a quarter-on-quarter *(QoQ) increase of 2.27 per cent from ₹567.53 crore. This corresponds to a year-on-year *(YoY) growth of 10.91 per cent.
Operating Profit stands at ₹46.07 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.29 per cent from ₹57.08 crore. This corresponds to a year-on-year *(YoY) decline of 1.71 per cent.
PBDT stands at ₹47.73 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 21.08 per cent from ₹60.48 crore. This corresponds to a year-on-year *(YoY) growth of 2.69 per cent.
Profit Before Tax stands at ₹27.55 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.96 per cent from ₹40.49 crore. This corresponds to a year-on-year *(YoY) decline of 0.90 per cent.
Net Profit stands at ₹20.58 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 31.33 per cent from ₹29.97 crore. This represents a 0.24 per cent year-on-year *(YoY) growth for the same year.
in ₹ cr
in ₹ cr
in ₹ cr
in ₹ cr
| Action | Target Price (₹) | Broker | Date | Reports |
|---|---|---|---|---|
| Data Not Found | ||||
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| IOL Chemicals | 1.61% | 3.57% | 19.20% | 8.14% | -17.79% | 29.34% |
| Bliss GVS Pharma | 1.71% | 9.14% | 27.29% | 59.07% | 67.03% | 108.25% |
| Dishman Carbogen | 0.92% | 8.07% | 1.21% | -39.44% | -45.36% | -24.00% |
| Novartis India | 0.93% | 0.04% | 5.41% | 27.27% | 15.83% | 22.95% |
| Unichem Labs. | 0.40% | 13.08% | 5.32% | -17.31% | -28.87% | -44.41% |
| Hikal | 1.79% | 9.99% | 4.12% | -15.71% | -25.21% | -56.70% |
| Morepen Labs. | 1.46% | 4.50% | 5.32% | 4.26% | -17.85% | -23.31% |
Managing Director : Varinder Gupta
Joint Managing Director : Vikas Gupta
Chairman & Independent Director : Rajender Mohan Malla
Independent Director : Harpal Singh
Company Sec. & Compli. Officer : Abhay Raj Singh
Director (Works) : Kushal Kumar Rana
Independent Director : SHARAD TYAGI
Executive Director : Abhiraj Gupta
Independent Director : Rajni Jha